aTyr Pharma to Present at Two Upcoming Investor Conferences

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
137
aTyr Pharma to Present at Two Upcoming Investor Conferences in September

SAN DIEGO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of immunology-based therapeutics, harnessing new pathway insights from human Physiocrine proteins, to treat patients suffering from severe, rare immune-mediated diseases, as well as various cancers, today announced its participation at two investor conferences in September:

  • A fireside chat at the 2017 Wells Fargo Healthcare Conference in Boston on Wednesday, September 6, at 8:30 a.m. Eastern Time.
  • A presentation at Ladenburg Thalmann’s 2017 Healthcare Conference in New York City on Tuesday, September 26 at 11:30 a.m. Eastern Time. This presentation will be webcast live through the "Investors" section of the aTyr Pharma website at  www.atyrpharma.com .  An audio replay will be available for at least 30 days following the initial presentation webcast. 

About aTyr Pharma

aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients using its knowledge of Physiocrine biology, a newly discovered set of immunological and physiological pathways. To date, aTyr has generated three innovative therapeutic programs with three different biologic modalities based on its knowledge of the Resokine pathway to treat patients suffering from severe, rare immune-mediated diseases, as well as various cancers. The Resolaris and iMod.Fc programs are agonists of the Resokine pathway designed to temper immune system engagement in diseases characterized by excessive immune cell involvement. aTyr’s third program, ORCA, represents a novel, proprietary pathway in immuno-oncology that utilizes antibody approaches to block the Resokine pathway and ‘release multiple brakes’ on the immune system in the tumor cell environment. aTyr has built an intellectual property estate, to protect its pipeline, comprising over 220 issued patents or allowed patent applications that are owned or exclusively licensed, including over 300 potential Physiocrine-based protein compositions. For more information, please visit http://www.atyrpharma.com .

Contact: Mark Johnson Sr. Director, Investor Relations mjohnson@atyrpharma.com 858-223-1163

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASUR's October Traffic Sees Mixed Results Across Regions

Updated Category News Views 77

A Patchwork of Gains and Losses Take a look at Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR), and you’ll see a mixed bag when it comes to October 2026’s passenger traffic. While some regions like Puerto Rico and Colombia took a step forward, others like Mexico and Costa Rica tripped up, resulting in an overall decline of 0.9% compared to last October....

Continue Reading
MCAP's Q3 Earnings: Sizing Up the Tech Game

Updated Category News Views 102

Quarterly Results: The Numbers to Watch Alright, here's the scoop from MCAP Inc.: they just tossed their hat in the quarterly earnings ring, flexing a third quarter EPS of $0.15 a share. Not exactly champagne-popping numbers, but hey, let's not throw out the party favors just yet. Revenues rolled in at a neat $26.7 million, with EBITDA tagging along at $5.2 million. So,...

Continue Reading
Pure Hockey Expands in SoCal: New Store in El Segundo

Updated Category News Views 7

Another Marker on Pure Hockey's Expansion Path Look, you might not have pegged California as a hockey hotbed a few decades back, but here we are, with Pure Hockey planting yet another flag in El Segundo. It marks their fifth outpost in the Golden State, enhancing access for players in the South Bay area. Makes you think about how far the game’s roots have spread across...

Continue Reading
Habitat for Humanity AZ's Unique Gala: An Overview

Updated Category News Views 6

Mark Your Calendars: A Night to Celebrate Listen up, Central Arizona, because I'm giving you the lowdown on Habitat for Humanity Central Arizona's big night out. "Blueprints & Blue Jeans" - it's the gala that's ditching the formalities for some good old-fashioned community fun, but with a seriously important mission at its heart. Mark your calendars for Friday, March 5,...

Continue Reading
WIC 2026: Global Connectivity and Cyber Futures

Updated Category News Views 117

Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...

Continue Reading
Encore Boston Harbor Workers Triumph After 62-Day Strike

Updated Category News Views 16

Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...

Continue Reading
Yiren Digital Faces Class Action by Investors

Updated Category News Views 57

Yiren's Stormy Seas: A Tale of Instability If you're holding a stake in Yiren Digital Ltd. (NYSE: YRD), you're likely feeling the heat right now. It's been a ride down a bumpy road with stock prices taking a nosedive—plummeting 44.05% on news that's got investors seeing red. The Nuts and Bolts of the Class Action What's the big fuss, you ask? Well, the lawsuit is no...

Continue Reading
Esperto's Space Health Tech Eyes Terrestrial Gains

Updated Category News Views 5

The cosmos isn't just a playground for astronauts. It's a proving ground for the next wave of medical innovation, courtesy of Esperto Medical. They're trotting into uncharted territory with the Translational Research Institute for Space Health (TRISH) grant in hand, determined to transform healthcare both in space and on our own turf. Groundbreaking Tech for Extreme...

Continue Reading
Teneo Expands Financial Advisory in Canada, Eyes Talent

Updated Category News Views 48

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

Continue Reading
XCMG Spurs 'AI + Construction' Innovation at Event

Updated Category News Views 107

XCMG's Big Push for Smarter Machinery China's construction machinery titan XCMG just wrapped up a fireworks show of innovation in Xuzhou, highlighting some sharp AI-driven machinery projects. Their recent 'AI + Construction Machinery' competition pulled in minds from over 20 countries, all aiming to rethink how these hulking machines operate. AI and Machinery: A Match...

Continue Reading

Top 5 Most Recently Viewed Articles

Menarini Group's Promising Insights on ELZONRIS for Hematology

Updated Category News Views 193

Menarini Group Shares New Insights on ELZONRIS® at Hematology Meeting The Menarini Group, a leading global pharmaceutical and diagnostics company, is set to showcase new data regarding ELZONRIS® (tagraxofusp-erzs) at a prestigious hematology event, the American Society of Hematology (ASH) Annual Meeting and Exposition. Notable findings from five abstracts, including two...

Continue Reading
ALZpath and Siemens Team Up for Advanced Alzheimer's Testing

Updated Category News Views 354

ALZpath and Siemens Healthineers Form Strategic Partnership ALZpath is thrilled to announce a significant licensing agreement with Siemens Healthineers. This collaboration marks a pivotal enhancement in the accessibility of diagnostic testing for Alzheimer's disease. The agreement involves the use of ALZpath's proprietary pTau217 antibody, a remarkable tool for...

Continue Reading
Monte Rosa Therapeutics Unveils Promising Cancer Treatment Data

Updated Category News Views 123

Monte Rosa Therapeutics Presents Groundbreaking Data Cyclin E1-directed molecular glue degraders (MGDs) show considerable potential as a novel therapeutic approach that directly targets a frequently amplified non-enzymatic driver oncogene. This is particularly relevant for multiple solid tumors. Impact of Cyclin E1 MGDs on Tumor Growth Recent data highlight that these...

Continue Reading
Manhattan Review Rolls Out Free SAT Vocabulary Training Tool

Updated Category News Views 171

Unlocking Potential with a Free Resource Nothing beats stepping up your game, especially when it comes to education. Manhattan Review just launched a free SAT vocabulary training tool that’s packing 3,000 words, and it's making waves. This isn’t just a flashy gimmick; it’s a deliberate move to prepare students heading into one of the most important tests of their...

Continue Reading
Exploring the Marvels of Chinese Ancient Architecture Worldwide

Updated Category News Views 309

A Journey Through Ancient Chinese Architecture On the fertile grounds where the essence of Chinese civilization flourishes, magnificent ancient architecture tells a story like no other. The beauty of these structures is not just in their design but in the craftsmanship and history infused within each brick and tile. The recent initiative, led by passionate ambassadors of...

Continue Reading